Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 83.14
-1.78 (-2.10%)
Sep 11, 2026, 3:00 PM CST
SHA:688016 Market Cap
SHA:688016 has a market cap or net worth of 10.05 billion as of September 11, 2026. Its market cap has decreased by -24.66% in one year.
Market Cap
10.05B
Enterprise Value
7.90B
Revenue
1.43B
Ranking
n/a
PE Ratio
17.44
Stock Price
83.14
ChartMarket Cap Chart
Since July 22, 2019, SHA:688016's market cap has decreased from 11.39B to 10.05B, a decrease of -11.83%. That is a compound annual growth rate of -1.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.05B | -9.35% |
| Dec 31, 2025 | 11.08B | -17.55% |
| Dec 31, 2024 | 13.44B | -16.51% |
| Dec 29, 2023 | 16.10B | 18.33% |
| Dec 30, 2022 | 13.61B | -24.00% |
| Dec 31, 2021 | 17.90B | -0.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shandong Weigao Blood Purification Products | 12.86B |
| Insight Lifetech | 12.36B |
| MeHow Innovative | 12.11B |
| Jafron Biomedical | 11.59B |
| Cofoe Medical Technology | 11.55B |
| Qingdao NovelBeam Technology | 9.68B |
| Qingdao Haier Biomedical Co.,Ltd | 9.64B |
| Beijing Balance Medical Technology | 9.29B |